Infectious Disease General
RSSArticles
-
TMC125 (Etravirine), a Second Generation Non-Nucleoside Reverse Transcriptase Inhibitor
The Non-nucleoside Reverse Transcriptase inhibitors (nnRTI's) including both efavirenz and nevirapine have intrinsic in vitro activity superior to all the other classes of antiretroviral agents. Clinical trials including patients who have been followed now for many years on efavirenz have demonstrated the durability, as well as potency, of these agents. -
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Study: Long-Term Use of Clopidogrel for DES Patients
Drug Labels A Prescription for Misunderstanding?; Beta-Blockers and Depression Unlinked?; FDA Actions -
Updates: Long-Term Care Facilities and VRE; Gay Men and Occult GC
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: HRT - Position Paper Places Benefits in Question
-
Updates: Antiretroviral Therapy and Pregnancy; Cryptococcosis on Vancouver Island; Foodborne Outbreaks
-
Parvovirus B19 Transmissions During Thoracic Surgery from a Pooled Plasma Product
-
Updates: Mosquitoes and Patients with HIV; Pneumococcal Vaccination in SLE and RA; Highly Resistant GC Marches Toward U.S.
-
Smallpox vaccination of some health care workers may not go far enough